We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

190 hedge funds and large institutions have $1.4B invested in Dr. Reddy's Laboratories in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 79 increasing their positions, 55 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 7

44% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 55

9% more funds holding

Funds holding: 174190 (+16)

1.76% more ownership

Funds ownership: 72.52%74.28% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less capital invested

Capital invested by funds: $1.41B → $1.4B (-$7.13M)

54% less call options, than puts

Call options by funds: $707K | Put options by funds: $1.52M

Holders
190
Holders Change
+16
Holders Change %
+9.2%
% of All Funds
5.09%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
24
Increased
79
Reduced
55
Closed
7
Calls
$707K
Puts
$1.52M
Net Calls
-$814K
Net Calls Change
-$872K

RDY Hedge Fund Activity: Q2 2015 in Review

190 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2015, worth a combined $1.4B — down 0.51% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new RDY positions and 7 closed out — a net gain of 17 holders — while 79 added to existing stakes and 55 trimmed.

The largest buyer was AQR Capital Management, adding an estimated $16.2M. The largest seller was Sectoral Asset Management, cutting an estimated $37.6M.

  • 190 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2015, up from 174 in Q1 2015.
  • Funds reported $1.4B of Dr. Reddy's Laboratories stock for Q2 2015, down 0.51% quarter-over-quarter.
  • 24 funds opened new Dr. Reddy's Laboratories positions in Q2 2015 and 7 closed out, a net change of +17 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q2 2015 was AQR Capital Management, an estimated $16.2M added.
  • The largest Dr. Reddy's Laboratories seller in Q2 2015 was Sectoral Asset Management, an estimated $37.6M sold.

Based on aggregated 13F filings for Q2 2015.